The latest price target for AngioDynamics (NASDAQ:ANGO) was reported by HC Wainwright & Co. on December 10, 2024. The analyst firm set a price target for $14.00 expecting ANGO to rise to within 12 months (a possible 57.48% upside). 10 analyst firms have reported ratings in the last year.

The latest analyst rating for AngioDynamics (NASDAQ:ANGO) was provided by HC Wainwright & Co., and AngioDynamics reiterated their buy rating.

The last upgrade for AngioDynamics Inc happened on April 5, 2024 when Oppenheimer raised their price target to $12. Oppenheimer previously had a perform for AngioDynamics Inc.

The last downgrade for AngioDynamics Inc happened on April 17, 2023 when Raymond James changed their price target from $14 to $13 for AngioDynamics Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AngioDynamics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AngioDynamics was filed on December 10, 2024 so you should expect the next rating to be made available sometime around December 10, 2025.

While ratings are subjective and will change, the latest AngioDynamics (ANGO) rating was a reiterated with a price target of $14.00 to $14.00. The current price AngioDynamics (ANGO) is trading at is $8.89, which is out of the analyst’s predicted range.